Chlamydia trachomatis diagnostics

Sexually Transmitted Infections

Volumn 78, Issue 4, 2002, Pages 232-234

  Chernesky, M A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; ENZYME IMMUNOASSAY; HUMAN; NUCLEIC ACID AMPLIFICATION; NUCLEIC ACID HYBRIDIZATION; PRIORITY JOURNAL; SHORT SURVEY;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REAGENT KITS, DIAGNOSTIC;

EID: 0036053232     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.78.4.232     Document Type: Short Survey

References (28)

1. Chlamydial serology: Comparative diagnostic value of immunoblotting, microimmunofluorescence test, and immunoassays using different recombinant proteins as antigens
2. Detection of Chlamydia trachomatis antigens in urine as an alternative to swabs and cultures
3. Evaluation of three immunoassays for detection of Chlamydia trachomatis in urine specimens from asymptomatic males
4. Confirmatory assay increases specificity of the Chlamydiazyme test for Chlamydia trachomatis infection of the cervix
5. Comparison of a polymer conjugate-enhanced enzyme immunoassay to ligase chain reaction for diagnosis of Chlamydia trachomatis in endocervical swabs
6. Evaluation of the Gen-Probe PACE 2 and the Microtrak enzyme immunoassay for diagnosis of Chlamydia trachomatis in urogenital samples
7. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in swab specimens by the Hybrid Capture II and PACE 2 nucleic acid probe tests
8. Ability of the Digene Hybrid Capture II test to identify Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens
9. Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix
10. Diagnosis of Chlamydia trachomatis endocervical infections by a commercial polymerase chain reaction assay
11. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests
12. Diagnosis of Chlamydia trachomatis infections in men and women by testing first-void urine by ligase chain reaction
13. Comparison of performances of two commercially available tests, a PCR assay and a ligase chain reaction test, in detection of urogenital Chlamydia trachomatis infection
14. Multicenter evaluation of the BDProbeTec ET system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs
15. Expanded gold standard in the diagnosis of Chlamydia trachomatis in a low prevalence population: Diagnostic efficacy of tissue culture, direct immunofluorescence, enzyme immunoassay, PCR and serology
16. Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women
17. Pooling cervical swabs and testing by ligase chain reaction accurate and cost-saving strategies for diagnosis of Chlamydia trachomatis
18. Current methods of laboratory diagnosis of Chlamydia trachomatis infections
19. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: Identification of urinary substances associated with inhibition and removal of inhibitory activity
20. Diff-quick stain as a simplified alternative to Papanicolaou stain for determination of quality of endocervical specimens submitted for PCR detection of Chlamydia trachomatis
21. Evaluation of an automated liquid-handling system (Tecan Genesis RSP 100) in the Abbott LCx assay for Chlamydia trachomatis
22. Performance of transcription-mediated amplification and ligase chain reaction assays for detection of chlamydial infection in urogenital samples obtained by invasive and noninvasive methods
23. Vulval swabs as alternative specimens for ligase chain reaction detection of genital chlamydial infection in women
24. The vaginal introitus: A novel site for Chlamydia trachomatis testing in women
25. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics - A cost-effectiveness analysis of three strategies
26. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women (implications for a National Chlamydia Control Strategy)
27. Asymptomatic non-ulcerative genital tract infections in a rural Ugandan population
28. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study